Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective

Michael Triebwasser, David M. Barrett, Hamid Bassiri, Nancy Bunin, Caitlin W. Elgarten, Jason L. Freedman, Abdallah S. Geera, Dimitri Monos, Michele P. Lambert, Timothy S. Olson, Alix E. Seif, Michele Paessler, Whitney Petrosa, Anne F. Reilly, Neil Romberg, Kathleen E. Sullivan, Ghazal Z. Quinn, Edward M. Behrens, David T. Teachey